Novavax’s (NVAX) Shares Rise on FDA Filing for COVID Jab Posted byZacks Equity Research February 1, 2022 Leave a comment on Novavax’s (NVAX) Shares Rise on FDA Filing for COVID Jab After a series of delays, Novavax (NVAX) finally files a regulatory application with the FDA seeking emergency use authorization of its COVID-19 vaccine.